PINL:GRPOF - Post by User
Comment by
Davesnothereon Apr 28, 2021 7:31am
208 Views
Post# 33080795
RE:This
RE:ThisI like this line from today's news release :
We are seeking guidance from the Malta Medicines Authority on Tetra's clinical development program of REBORN2 as we plan for global commercialization of QIXLEEF," said Guy Chamberland, CEO and CRO of Tetra Bio-Pharma Inc
WOW